Search research articles
Contact Us
Filters
Showing results (601-610 of 645) with videos related to
Page
of 65
Sort By:
Cancer Medicine
|
June 8, 2019
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
Barbara Mora, Elisa Rumi, Paola Guglielmelli, et al.
Journal of Clinical Medicine
|
July 31, 2020
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians
Nicola Scichilone, Peter John Barnes, Salvatore Battaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 26, 2013
Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis
John Koreth, Joseph Pidala, Waleska S Perez, et al.
Blood
|
October 15, 2011
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Luca Malcovati, Elli Papaemmanuil, David T Bowen, et al.
Plos One
|
October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2
Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
American Journal of Hematology
|
August 14, 2012
Clinical significance of genetic aberrations in secondary acute myeloid leukemia
Jelena D Milosevic, Ana Puda, Luca Malcovati, et al.
Blood Advances
|
March 5, 2021
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis
Sebastiano Rontauroli, Sara Castellano, Paola Guglielmelli, et al.
European Journal of Haematology
|
November 22, 2007
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study
John Porter, Renzo Galanello, Giuseppe Saglio, et al.
American Journal of Hematology
|
November 24, 2016
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms
Lisa Pieri, Chiara Paoli, Umberto Arena, et al.
The New England Journal of Medicine
|
December 12, 2013
Somatic mutations of calreticulin in myeloproliferative neoplasms
Thorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, et al.
Page
of 65
Search research articles
Search
Showing results (601-610 of 645) with videos related to
Sort By:
Page
of 65
Cancer Medicine
|
June 8, 2019
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
Barbara Mora, Elisa Rumi, Paola Guglielmelli, et al.
Journal of Clinical Medicine
|
July 31, 2020
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians
Nicola Scichilone, Peter John Barnes, Salvatore Battaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 26, 2013
Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis
John Koreth, Joseph Pidala, Waleska S Perez, et al.
Blood
|
October 15, 2011
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Luca Malcovati, Elli Papaemmanuil, David T Bowen, et al.
Plos One
|
October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2
Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
American Journal of Hematology
|
August 14, 2012
Clinical significance of genetic aberrations in secondary acute myeloid leukemia
Jelena D Milosevic, Ana Puda, Luca Malcovati, et al.
Blood Advances
|
March 5, 2021
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis
Sebastiano Rontauroli, Sara Castellano, Paola Guglielmelli, et al.
European Journal of Haematology
|
November 22, 2007
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study
John Porter, Renzo Galanello, Giuseppe Saglio, et al.
American Journal of Hematology
|
November 24, 2016
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms
Lisa Pieri, Chiara Paoli, Umberto Arena, et al.
The New England Journal of Medicine
|
December 12, 2013
Somatic mutations of calreticulin in myeloproliferative neoplasms
Thorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, et al.
Page
of 65